Additionally, TRF2 may assist tumor cells in evading immune surveillance, since inhibition of TRF2 has been shown to promote the activation of NK cells [78].From the perspective of telomere biology, NEK7 and SP1 may also emerge as potential targets for future cancer therapies. Here, SP1 is linked to cancer.